InvestorsHub Logo
Followers 10
Posts 801
Boards Moderated 1
Alias Born 11/10/2008

Re: midastouch017 post# 1191

Friday, 11/05/2021 8:41:14 AM

Friday, November 05, 2021 8:41:14 AM

Post# of 1673
I still see ORMPs major market for thr COVID pill being developing nations which probably wouldn't have as easy access to treatment like this. Robust antibody/immunity results from phase one human trials with our 3 spike protein in a pill would still do a lot for the stock. Obviously still here for oral insulin but worst case scenario COVID pill has left us well funded (think I saw around 180 million in cash after $50 million stock offering this week) to get through phase 3 trials with 0801 and other phase 2 trials (hopefully phase 3 in future)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ORMP News